Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 238-883-1 | CAS number: 14814-09-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
In the key acute oral toxicity study conducted according to OECD Test Guideline 423 and in compliance with GLP (Eurofins / BSL Bioservice Scientific Laboratories, 2019, reliability score 1), the LD50 value for 3-(triethoxysilyl)propanethiol (CAS No. 14814-09-6, EC No. 238-883-1) in the Wistar rat was >2000 mg/kg bw.
For dermal toxicity, the key study for 3-(triethoxysilyl)propanethiol pre-dates GLP but was conducted according to a protocol equivalent or similar to OECD Test Guideline 402 (Carnegie-Mellon Institute of Research, 1976, reliability score 2). The LD50 was 2.52 ml/kg bw (approximately 2500 mg/kg bw) in male albino rabbit.
The acute inhalation toxicity endpoint is waived since reliable data for the acute oral and dermal endpoints are available.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2019/03/28 - 2019/04/18
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- 2001/12/17
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Version / remarks:
- 2008/05/30
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Version / remarks:
- 2002/12
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- no
- Specific details on test material used for the study:
- STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature, protected from light
- Stability under test conditions: stable
- Solubility and stability of the test substance in the solvent/vehicle: stable
- Reactivity of the test substance with the solvent/vehicle of the cell culture medium: not applicable
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: For all animals of the first step, 2.0068 g of the test item was diluted with the vehicle to yield a final volume of 10 ml and to achieve a dose of 2000 mg/kg bw at a dose volume of 10 ml/kg bw. For all animals of the second step, 2.0002 g of the test item was diluted with the vehicle to yield a final volume of 10 ml and to achieve a dose of 2000 mg/kg bw at a dose volume of 10 ml/kg bw.
- Preliminary purification step (if any): none
- Final dilution of a dissolved solid, stock liquid or gel: not applicable
- Final preparation of a solid: not applicable
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River, 97633 Sulzfeld, Germany
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation: 8 – 10 weeks
- Weight at study initiation: Step 1: 153 – 177 g; Step 2: 189 – 200 g
- Fasting period before study: Prior to the administration food was withheld from the test animals for 16 to 19 hours (access to water was permitted).
- Housing: The animals were kept in groups in IVC cages, type III H, polysulphone cages on Altromin saw fibre bedding
- Diet (e.g. ad libitum): Altromin 1324 maintenance diet for rats and mice, ad libitum
- Water (e.g. ad libitum): tap water, ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3
- Humidity (%): 55 +/- 10
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12/12
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 0.2 g/ml
- Amount of vehicle (if gavage): not specified
- Justification for choice of vehicle: This vehicle was chosen due to its non-toxic characteristics.
- Lot/batch no. (if required): MKCG3257
- Purity: not specified
MAXIMUM DOSE VOLUME APPLIED: 10 ml/kg bw
DOSAGE PREPARATION (if unusual): For all animals of the first step, 2.0068 g of the test item was diluted with the vehicle to yield a final volume of 10 ml and to achieve a dose of 2000 mg/kg bw at a dose volume of 10 ml/kg bw. For all animals of the second step, 2.0002 g of the test item was diluted with the vehicle to yield a final volume of 10 ml and to achieve a dose of 2000 mg/kg bw at a dose volume of 10 ml/kg bw.
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: The starting dose was selected to be 2000 mg/kg bw. No compound-related mortality was recorded for any animal of step 1 or 2. Based on these results and according to the acute toxic class method regime no further testing was required. - Doses:
- 2000 mg/kg bw in step 1 and 2
- No. of animals per sex per dose:
- 3F per step 1 and 2, overall 6 animals used
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: The animals were weighed on day 1 (prior to the administration) and on days 8 and 15.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, gross pathology - Statistics:
- Not used
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- The test item showed no mortality and no other acute oral toxicity characteristics after a single dose administration in step 1 and 2.
- Clinical signs:
- other: No specific sings of systemic toxicity were seen in any of the test animals.
- Gross pathology:
- No specific findings were seen during pathology examination.
- Other findings:
- No
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In the key acute oral toxicity study conducted according to OECD Test Guideline 423 and in compliance with GLP (reliability score 1), the LD50 for 3-(triethoxysilyl)propanethiol in the Wistar rat was >2000 mg/kg bw.
Reference
Table 1: Absolute Body Weights g and Body Weight Change
Step |
Animal No. / Sex |
Starting Dose (mg/kg bw) |
|
BW (g) |
|
Body Weight Change in Comparison to Day 1 (%) |
Day 1 |
Day 8 |
Day 15 |
Day 15 |
|||
1 |
1 / Female |
2000 |
177 |
208 |
215 |
21 |
2 / Female |
158 |
193 |
202 |
28 |
||
3 / Female |
153 |
173 |
184 |
20 |
||
2 |
4 / Female |
2000 |
189 |
217 |
224 |
19 |
5 / Female |
193 |
195 |
214 |
11 |
||
6 / Female |
200 |
221 |
225 |
13 |
Table 2: Findings of the Necropsy - Individual data
Step |
Animal No. / Sex |
Starting Dose (mg/kg bw) |
Organ |
Macroscopic Findings |
1 |
1 / Female |
2000 |
- |
nsf |
2 / Female |
- |
nsf |
||
3 / Female |
- |
nsf |
||
2 |
4 / Female |
- |
nsf |
|
5 / Female |
- |
nsf |
||
6 / Female |
- |
nsf |
nsf = no specific findings
Table 3: LD50Cut-Off
Starting Dose (mg/kg bw) |
Number of Animals |
Number of Intercurrent Deaths |
LD50Cut-Off (mg/kg bw) |
2000 |
6 |
0 |
˃ 5000 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Key reliability score 1 study available
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1976
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- GLP compliance:
- no
- Test type:
- fixed dose procedure
- Limit test:
- yes
- Species:
- rabbit
- Strain:
- other: albino
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Carnegie-Mellon Institute of Research
- Age at study initiation: 3-5 months
- Diet: ad libitum
- Water: ad libitum - Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: the trunk
- Type of wrap if used: 'impervious sheeting'
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): maximum dose that can be retained is 16 to 20 ml/kg bw - Duration of exposure:
- 24 h
- Doses:
- 16, 8, 4, 2, 1 ml/kg bw
- No. of animals per sex per dose:
- 2M (16 ml/kg bw), 4M (8 ml/kg bw), 4M (4 ml/kg bw), 4M (2 ml/kg bw), 4M (1 ml/kg bw)
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Necropsy of survivors performed: yes - Statistics:
- Not specified
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 2.52 mL/kg bw
- Based on:
- test mat.
- 95% CL:
- ca. 1 - ca. 6.33
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 2 500 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Based on specific gravity 0.98 g/cm3
- Mortality:
- 2/2 (16 ml/kg bw), 4/4 (8 ml/kg bw), 2/4 (4 ml/kg bw), 2/4 (2 ml/kg bw), 1/4 (1 ml/kg bw)
- Clinical signs:
- other: Two prostrate at 'one day' (8 and 4 ml/kg bw), one prostrate at 'one day' (2 ml/kg bw). Erythema, ecchymosis, scabs, desquamation at application site, depending on dose.
- Gross pathology:
- In victims, livers were paled and mottled, spleens dark, kidneys congested. Nothing remarkable in survivors.
- Interpretation of results:
- Category 5 based on GHS criteria
- Remarks:
- Not classified according to Regulation (EC) No. 1272/2008
- Conclusions:
- In a study pre-dating GLP but conducted according to a protocol equivalent or similar to OECD Test Guideline 402 (reliability score 1), the acute dermal LD50 for 3-(triethoxysilyl)propanethiol in the male albino rabbit was 2.52 ml/kg bw (approximately 2500 mg/kg bw).
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 500 mg/kg bw
- Quality of whole database:
- Key reliability score 2 study available
Additional information
In the key acute oral toxicity study conducted according to OECD Test Guideline 423 and in compliance with GLP (Eurofins / BSL Bioservice Scientific Laboratories, 2019, reliability score 1), two groups, each of three female Wistar rats, were treated with 3-(triethoxysilyl)propanethiol by oral gavage administration at a dose of 2000 mg/kg bw. The test item was diluted with the vehicle corn oil at a concentration of 0.2 g/ml and administered at a dose volume of 10 ml/kg bw. All animals were examined for clinical signs several times on the day of dosing and once daily until the end of the 14-day observation period. Their body weights were recorded on day 1 (prior to the administration) and on days 8 and 15. All animals were necropsied and examined macroscopically. All animals gained weight during the study period. All animals survived until the end of the study without showing any sign of toxicity. At necropsy, no treatment-related macroscopic findings were observed in any animal of any step. The oral LD50 value for 3-(triethoxysilyl)propanethiol was >2000 mg/kg bw.
In a supporting acute oral toxicity study that pre-dates GLP but was conducted according to a protocol equivalent or similar to OECD Test Guideline 401 (Carnegie-Mellon Institute of Research, 1976, reliability score 2), male Wistar rats were exposed to 4, 8, and 16 ml/kg bw of undiluted 3-(triethoxysilyl)propanethiol via oral gavage. In the highest dose group (16 ml/kg bw), the animals were seen to be sluggish, with deep breathing, tremor-like muscular spasms and loss of coordination. The symptoms progressed to salivation and convulsions followed by the death of all three animals. Similar, but milder clinical signs were evident in the lower dose groups. In victims, petechial haemorrhages or congestion was observed in the lungs. This finding was accompanied with mottled livers, slightly speckled and congested kidneys and distended and liquid or gas-filled intestines and stomachs. Nothing remarkable was seen in survivors. The oral LD50 for 3-(triethoxysilyl)propanethiol in the male Wistar rat was 6.17 ml/kg bw (approximately 6050 mg/kg bw).
The key acute dermal toxicity study for 3-(triethoxysilyl)propanethiol pre-dates GLP but was conducted according to a protocol equivalent or similar to OECD Test Guideline 402 (Carnegie-Mellon Institute of Research, 1976, reliability score 2). Male albino rabbits (two to four per dose group) were exposed to 1, 2, 4, 8, and 16 ml/kg bw of undiluted 3-(triethoxysilyl)propanethiol applied to clipped intact trunk skin under occlusive conditions for 24 hours. Prostration was seen in one or two animals at 2 to 8 ml/kg bw. Erythema, ecchymosis, scabs and/or desquamation were evident at the application site for 1 to 16 ml/kg bw. In victims, livers were paled and mottled, spleens dark and kidneys congested. No remarkable findings were seen in survivors. The dermal LD50 for 3-(triethoxysilyl)propanethiol in the male albino rabbit was 2.52 ml/kg bw (approximately 2500 mg/kg bw).
No reliable data are available for acute inhalation toxicity, however a supporting study (Carnegie-Mellon Institute of Research, 1976, non-guideline / pre-GLP, reliability score 4) reported no deaths or adverse effects in the rat (species / sex not specified) after an 8-hour exposure to substantially saturated vapour of 3-(triethoxysilyl)propanethiol. In accordance with Column 2 of REACH Annex VIII, an acute toxicity study via the inhalation route (required in Section 8.5.2) does not need to be conducted as reliable data via the oral and dermal routes are available.
Justification for classification or non-classification
Based on the available information, 3-(triethoxysilyl)propanethiol does not require classification for acute toxicity according to Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.